Global Bioprosthetics Market Size Study, by Product (Allograft, Xenograft), by Application (Cardiovascular, Plastic Surgery & Wound Healing), and Regional Forecasts 2022-2032

The global bioprosthetics market is valued at approximately USD 5.66 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.40% over the forecast period 2024-2032. The increasing prevalence of cardiovascular diseases (CVD) and a rapidly aging global population are key drivers shaping market growth. Bioprosthetic devices, which involve the use of biological tissue in medical implantations, have gained widespread acceptance in treating various cardiovascular conditions such as heart valve disorders. The rising incidence of conditions like high blood pressure, strokes, and coronary heart disease has led to an increased demand for bioprosthetic heart valves, fueling market expansion. As per the Stroke Association, approximately 100,000 people experience strokes annually in the UK, highlighting the urgent need for advanced cardiovascular solutions.

The growing geriatric population further underpins market growth. According to the World Health Organization (WHO), the global population of individuals aged 60 years and older is projected to reach 2.1 billion by 2050. Sedentary lifestyles, increasing tobacco and alcohol consumption, and dietary imbalances contribute to the rising burden of cardiovascular diseases, which claim over 17.9 million lives annually worldwide. Given these statistics, the demand for bioprosthetic implants is expected to surge over the coming years. The advent of technological advancements in tissue engineering and biomaterials has further accelerated market growth, enabling the development of more durable and effective bioprosthetic solutions.

Investments in research and development (R&D) remain a critical factor in shaping the bioprosthetics industry. For instance, in June 2024, Esper Bionics, a leading developer of bioprosthetic technologies, secured USD 5 million in funding from YZR Capital, with additional co-financing from Horizon Capital and the European Bank for Reconstruction and Development. Such investments drive innovation and facilitate the introduction of next-generation bioprosthetic products. Furthermore, the increasing focus on minimally invasive procedures has led to the development of cutting-edge bioprosthetic valves, such as Medtronic's Avalus Ultra Bioprosthesis Valve, which enhances implantation ease and long-term patient outcomes.

From a regional perspective, North America held the largest revenue share in 2023, driven by advanced healthcare infrastructure, favorable reimbursement policies, and a high prevalence of cardiovascular conditions. The U.S. market, in particular, is witnessing substantial growth, with the Centers for Disease Control and Prevention (CDC) reporting that one person dies from CVD every 33 seconds. Meanwhile, the Asia-Pacific region is projected to experience the highest growth rate, fueled by rising awareness, an expanding healthcare sector, and increasing instances of hypertension and coronary heart disease in countries like China, India, and Thailand. The European market is also poised for growth, supported by robust R&D investments and growing adoption of minimally invasive bioprosthetic procedures.

Major market players included in this report are:
• Medtronic
• Abbott (St. Jude Medical, Inc.)
• Edwards Lifesciences Corporation
• LivaNova PLC (Sorin Group)
• Johnson & Johnson (Ethicon, Inc.)
• LeMaitre Vascular, Inc.
• Organogenesis Inc.
• Humacyte Global, Inc.
• Artivion, Inc. (CryoLife, Inc.)
• Braile Biomédica
• JenaValve
• Labcor Laboratories Ltda.
• Rua Life Sciences Plc (Aortech International Plc.)
• Meril Life Sciences
• LATTICE MEDICAL

The detailed segments and sub-segments of the market are explained below:

By Product:
• Allograft
• Xenograft

By Application:
• Cardiovascular
• Plastic Surgery & Wound Healing

By Region:
• North America
U.S.
Canada
Mexico
• Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
• Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
• Latin America
Brazil
Argentina
• Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait



Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape, including country-level trends across major regions.
• Competitive landscape with a comprehensive overview of major players and their market positioning.
• Analysis of key business strategies, mergers, acquisitions, and investment initiatives.
• Assessment of emerging trends, disruptive technologies, and future market outlook.
• Demand-side and supply-side analysis of the bioprosthetics market, including R&D advancements and innovation landscape.
• Comprehensive regulatory framework analysis influencing market trends across different regions.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.